Concepedia

Author

Ruifen Dong

Qilu Hospital of Shandong UniversityORCID

Also Known As

Dong, Ruifen, R Dong, RUIFEN DONG, Ruifen Dong, Ruohan Dong

34

Publications

862

Citations

16

H-Index

20

Concepts

All Affiliations

Qilu Hospital of Shandong UniversityShandong UniversityNorthwestern UniversityThe University of Texas MD Anderson Cancer CenterPeking Union Medical College Hospital
RD

About

Ruifen Dong is an author at Qilu Hospital of Shandong University specializing in medicine, radiation oncology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

239

2

Cell Biology

2

2

67

3

Obstetrics

2

2

123

4

Pathology

2

2

93

5

Immunology

1

1

45

Ruifen Dong

×

15

Publications

691

Citations

15

H-Index

YearCitations

A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA

Qing Zhang, Guohong Hu, Qifeng Yang,

Gynecologic Oncology

2013

101

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma

Ruifen Dong, Xiaolin Liu, Qing Zhang,

Oncotarget

2014

98

miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma

Yuqiong Wang, Xiyu Zhang, Wei Tang,

Cell Death and Differentiation

2017

71

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma

Ruifen Dong, Wenan Qiang, Haiyang Guo,

Journal of Hematology & Oncology

2016

50

Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells

Yugang Liu, Wenan Qiang, Xiaofei Xu,

Oncotarget

2015

45

Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma

Qing Zhang, Yinuo Li, Chunying Miao,

Cancer Letters

2018

45

miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma

Yu Wang, Yan Shi, Xiaolin Liu,

Oncology Reports

2014

43

<i>miR-106a</i> Represses the Rb Tumor Suppressor p130 to Regulate Cellular Proliferation and Differentiation in High-Grade Serous Ovarian Carcinoma

Zhaojian Liu, Elizabeth Gersbach, Xiyu Zhang,

Molecular Cancer Research

2013

43

Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma

Zhiwei Zhang, Chenggong Sun, Chengcheng Li,

Frontiers in Oncology

2020

43

Frequent <i>SLIT2</i> Promoter Methylation in the Serum of Patients with Ovarian Cancer

Ruifen Dong, Jinjin Yu, Hong Pu,

Journal of International Medical Research

2012

40

Page 1